×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| GKB OPHTHALMICS LTD. | 262.89 | -19.05 | 258.04 | -4.03 | 41.3 | |
| Shree Ganesh Biotech (India) L | 147.16 | 7.72 | 144.12 | 0.02 | 40.3 | 21.5 |
| Vineet Laboratories Limited | 181.32 | -57.07 | 180.99 | -6.19 | 39.4 |
GKB Ophthalmics Ltd., with Security Code 533212, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.6 | 7.0 | 6.5 | 6.4 | 9.7 | 7.2 | 6.8 | 7.3 | 8.6 | 8.2 |
| Expenses | 7.0 | 7.3 | 7.6 | 7.0 | 8.7 | 8.1 | 7.9 | 7.8 | 9.0 | 9.3 |
| Operating Profit | 0.6 | -0.2 | -1.0 | -0.5 | 1.0 | -0.9 | -1.0 | -0.4 | -0.4 | -1.0 |
| OPM % | 8.37% | -2.91% | -15.55% | -7.93% | 10.24% | -11.69% | -14.77% | -5.53% | -4.94% | -12.64% |
| Other Income | 0.1 | 0.0 | 1.7 | 0.3 | 0.1 | 0.1 | 1.7 | 0.2 | 0.1 | 0.1 |
| Interest | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 |
| Depreciation | 0.3 | 0.3 | 0.3 | 1.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.7 | 0.7 |
| Profit before tax | 0.1 | -0.9 | 0.0 | -2.2 | 0.1 | -1.8 | -0.3 | -1.3 | -1.4 | -2.0 |
| Tax % | 36.5% | -2.4% | 166.7% | -3.9% | 1.3% | -0.1% | -0.3% | -2.9% | -0.7% | -0.5% |
| Net Profit | 0.1 | -0.9 | 0.0 | -2.1 | 0.1 | -1.8 | -0.3 | -1.4 | -1.4 | -2.1 |
| EPS in Rs | 0.14 | -1.76 | 0.1 | -4.2 | 0.15 | -3.59 | -0.61 | -2.73 | -2.8 | -4.07 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.6 | 19.1 | 20.0 | 22.3 | 20.4 | 24.0 | 21.6 | 26.0 | 26.1 | 25.8 |
| Expenses | 17.0 | 19.2 | 20.4 | 20.9 | 20.7 | 24.7 | 21.6 | 25.0 | 26.2 | 26.8 |
| Operating Profit | 1.5 | -0.1 | -0.4 | 1.3 | -0.3 | -0.6 | 0.0 | 1.0 | -0.1 | -0.9 |
| OPM % | 8.3% | -0.7% | -1.9% | 6.1% | -1.6% | -2.5% | 0% | 4% | -0.2% | -3.7% |
| Other Income | 0.4 | 0.0 | 0.2 | 0.4 | 0.3 | 0.3 | 0.5 | 0.3 | 0.2 | 0.5 |
| Interest | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.6 | 0.6 | 0.6 | 0.6 |
| Depreciation | 0.4 | 0.4 | 1.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 |
| Profit before tax | 1.1 | -0.9 | -2.2 | 0.5 | -1.2 | -1.4 | -0.8 | 0.0 | -1.1 | -1.9 |
| Tax % | 2.1% | -18.5% | -4.6% | 0.2% | -0.1% | -0.1% | -26% | 430.8% | -4.9% | -2.6% |
| Net Profit | 1.1 | -1.1 | -2.1 | 0.5 | -1.2 | -1.4 | -0.9 | 0.1 | -1.2 | -1.9 |
| EPS in Rs | 1 | -2 | -3 | 1 | -2 | -2 | -1 | 0 | -2 | -4 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 13% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 3% |
| 3 Years: | 0% |
| TTM: | -20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | -5% |
| 1 Year: | -9% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 9% |
| 3 Years: | 16% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -3% |
| 3 Years: | 0% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | -5% |
| 1 Year: | -9% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|